$MDWK
MDWerks, Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315222030420 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $78.42K $49.65K $2.120K
YoY Change 3599.06% 355.09% -84.56%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $78.42K $49.65K $2.120K
YoY Change 3599.06% 355.11% -84.56%
Operating Profit -$49.65K
YoY Change 354.98%
Interest Expense $0.00 -$6.830K
YoY Change -100.0% 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$78.42K -$49.65K -$8.950K
YoY Change 776.2% 355.09% -56.45%
Income Tax
% Of Pretax Income
Net Earnings -$78.42K -$49.65K -$8.950K
YoY Change 776.2% 355.11% -56.45%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00 -$496.90
COMMON SHARES
Basic Shares Outstanding 18.01M shares 18.01M shares
Diluted Shares Outstanding 18.01M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.72K
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $23.72K $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets -$23.72K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $23.72K $0.00
Total Long-Term Assets -$23.72K $0.00
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.48K $0.00 $1.139K
YoY Change 2927.04% -100.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $210.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $128.1K $49.65K $230.8K
YoY Change -44.51% -78.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $128.1K $49.65K $230.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $128.1K $49.65K $230.8K
YoY Change -44.51% -78.29%
SHAREHOLDERS EQUITY
Retained Earnings -$430.7K -$352.3K -$294.0K
YoY Change 46.5%
Common Stock $122.3K $18.01K $18.01K
YoY Change 578.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$128.1K -$49.65K -$230.8K
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$78.42K -$49.65K -$8.950K
YoY Change 776.2% 355.11% -56.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$54.55K -$49.65K -$1.050K
YoY Change 5095.24% 358.87%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 54.55K 49.65K 1.050K
YoY Change 5095.24% 358.87%
NET CHANGE
Cash From Operating Activities -54.55K -49.65K -1.050K
Cash From Investing Activities
Cash From Financing Activities 54.55K 49.65K 1.050K
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$54.55K -$49.65K -$1.050K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q3 us-gaap Assets
Assets
usd
CY2021Q4 us-gaap Assets
Assets
usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
dei Document Type
DocumentType
10-Q
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
MDWK Noncash Investing Forgivenessof Debt
NoncashInvestingForgivenessofDebt
usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001295514
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
MDwerks, Inc.
dei Entity File Number
EntityFileNumber
000-56299
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1095411
dei Entity Address Address Line1
EntityAddressAddressLine1
12 Park Mirage Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Rancho Mirage
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92270
dei City Area Code
CityAreaCode
(403)
dei Local Phone Number
LocalPhoneNumber
988-2005
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
MDWK
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18010208 shares
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1139 usd
CY2022Q3 MDWK Advances Payable Current
AdvancesPayableCurrent
49652 usd
CY2021Q4 MDWK Advances Payable Current
AdvancesPayableCurrent
19659 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
210000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
49652 usd
CY2021Q4 us-gaap Liabilities
Liabilities
230798 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18010208 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18010208 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18010208 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18010208 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
18010 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18010 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
274639 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35195 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-352301 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-294003 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-49652 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-230798 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49652 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10913 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58298 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18676 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
49652 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
10913 usd
us-gaap Operating Expenses
OperatingExpenses
58298 usd
us-gaap Operating Expenses
OperatingExpenses
18676 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-49652 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10913 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-58298 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18676 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
65599 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
65599 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-49652 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10913 usd
us-gaap Net Income Loss
NetIncomeLoss
-58298 usd
us-gaap Net Income Loss
NetIncomeLoss
46923 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18010208 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18010208 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18010208 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18010208 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18010208 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18010208 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18010208 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18010208 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-275599 usd
us-gaap Net Income Loss
NetIncomeLoss
46923 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-228676 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-217763 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10913 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-228676 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-230798 usd
us-gaap Net Income Loss
NetIncomeLoss
-58298 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
239444 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-49652 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-239444 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-239444 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-49652 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
239444 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-49652 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-49652 usd
us-gaap Net Income Loss
NetIncomeLoss
-58298 usd
us-gaap Net Income Loss
NetIncomeLoss
46923 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
65599 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
23 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1139 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
93 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59437 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18606 usd
MDWK Proceeds From Advances
ProceedsFromAdvances
59437 usd
MDWK Proceeds From Advances
ProceedsFromAdvances
18606 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
59437 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18606 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
MDWK Noncash Investing Forgivenessof Debt
NoncashInvestingForgivenessofDebt
239444 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-352301 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_znIhDvJtfOyb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zR28KgGoDvE5">Use of Estimates and Assumptions</span></b> - The preparation of financial statements in accordance with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Net Income Loss
NetIncomeLoss
-58298 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1139 usd
CY2014Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
210000 usd
CY2014Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
210000 usd
CY2014Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0005
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.0999 pure
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
210000 usd
CY2022Q3 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
239444 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18010208 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18010208 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares

Files In Submission

Name View Source Status
0001493152-22-030420-index-headers.html Edgar Link pending
0001493152-22-030420-index.html Edgar Link pending
0001493152-22-030420.txt Edgar Link pending
0001493152-22-030420-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
mdwk-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mdwk-20220930_def.xml Edgar Link unprocessable
mdwk-20220930_lab.xml Edgar Link unprocessable
mdwk-20220930_cal.xml Edgar Link unprocessable
mdwk-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed